Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome Prevention and Control in China:Statistics,Challenges,and the Road Ahead  

作　　者：Sitong Luo Ning Wang 

机构地区：[1]Vanke School of Public Health,Tsinghua University,Beijing 100084,China [2]Institute for Healthy China,Tsinghua University,Beijing 100084,China [3]Chinese Center for Disease Control and Prevention,Beijing 102206,China

出　　处：《Infectious Diseases & Immunity》2024年第4期149-151,共3页感染性疾病与免疫（英文）

基　　金：supported by the Capital’s Funds for Health Improvement and Research(CFH:2024-2G-4402).

摘　　要：1.Background,Forty years have passed since the initial discovery and isolation of the human immunodeficiency virus(HIV)in 1984.[1,2]At the end of 2022,approximately 85.6 million people had been infected with the virus,and 40.4 million had died from acquired immunodeficiency syndrome(AIDS)-related illnesses globally.[3]

关 键 词：IMMUNODEFICIENCY IMMUNODEFICIENCY globally 

分 类 号：R512.91[医药卫生—内科学]